
Project overview
Antimicrobial resistance (AMR) is a major healthcare challenge. Prosthetic joint infections, often caused by Staphylococcus aureus and Staphylococcus epidermidis, are difficult to treat because these bacteria form biofilms that protect them from antibiotics and host defenses.
Within the NWO-funded EPIC (Endolysin-based Protective Implant nanoCarriers) consortium, ACTA, the University of Twente, Micreos, LipoCoat, and clinical partners are developing innovative endolysin-loaded nanocarriers to prevent and treat implant-associated infections.
We seek a highly motivated PhD candidate to investigate the antimicrobial efficacy, anti-biofilm activity, biosafety, and host compatibility of novel endolysin formulations.
Your role
You will:
You will be based in both the Department of Preventive Dentistry and the Department of Oral Cell Biology at ACTA and work in an interdisciplinary environment spanning microbiology, cell biology, biomaterials, and host-microbe interactions.
The supervisory team consists of Prof. dr. Bastiaan Krom, Prof. dr. Astrid Bakker, dr. ing. Michel Hoogenkamp, and dr. Jianfeng Jin.
You have:
A challenging position in a socially engaged organisation. At ACTA, you contribute to education, research and service for a better world. And that is valuable. So in return for your efforts, we offer you:
We also offer you attractive fringe benefits and regulations. Some examples:
ACTA is the joint Faculty of Dentistry of the University of Amsterdam and Vrije Universiteit Amsterdam and is internationally recognized for its research, education, and patient care in oral health.
Are you interested in this position and do you believe that your experience will contribute to the further development of our university? In that case, we encourage you to submit your application.
Please submit:
For questions, contact:
dr. ing. Michel Hoogenkamp
Department of Preventive Dentistry, ACTA
[email protected]
Applications will be reviewed on a rolling basis until the position is filled. The first round of interviews is expected to take place at the end of November, and the preferred start date for the successful candidate is 1 February 2027.
Submitting a diploma is part of the application process.
Applications received by e-mail will not be considered.
Acquisition in response to this advertisement is not appreciated.

Project overview
Antimicrobial resistance (AMR) is a major healthcare challenge. Prosthetic joint infections, often caused by Staphylococcus aureus and Staphylococcus epidermidis, are difficult to treat because these bacteria form biofilms that protect them from antibiotics and host defenses.
Within the NWO-funded EPIC (Endolysin-based Protective Implant nanoCarriers) consortium, ACTA, the University of Twente, Micreos, LipoCoat, and clinical partners are developing innovative endolysin-loaded nanocarriers to prevent and treat implant-associated infections.
We seek a highly motivated PhD candidate to investigate the antimicrobial efficacy, anti-biofilm activity, biosafety, and host compatibility of novel endolysin formulations.
Your role
You will:
You will be based in both the Department of Preventive Dentistry and the Department of Oral Cell Biology at ACTA and work in an interdisciplinary environment spanning microbiology, cell biology, biomaterials, and host-microbe interactions.
The supervisory team consists of Prof. dr. Bastiaan Krom, Prof. dr. Astrid Bakker, dr. ing. Michel Hoogenkamp, and dr. Jianfeng Jin.
You have:
A challenging position in a socially engaged organisation. At ACTA, you contribute to education, research and service for a better world. And that is valuable. So in return for your efforts, we offer you:
We also offer you attractive fringe benefits and regulations. Some examples:
ACTA is the joint Faculty of Dentistry of the University of Amsterdam and Vrije Universiteit Amsterdam and is internationally recognized for its research, education, and patient care in oral health.
Are you interested in this position and do you believe that your experience will contribute to the further development of our university? In that case, we encourage you to submit your application.
Please submit:
For questions, contact:
dr. ing. Michel Hoogenkamp
Department of Preventive Dentistry, ACTA
[email protected]
Applications will be reviewed on a rolling basis until the position is filled. The first round of interviews is expected to take place at the end of November, and the preferred start date for the successful candidate is 1 February 2027.
Submitting a diploma is part of the application process.
Applications received by e-mail will not be considered.
Acquisition in response to this advertisement is not appreciated.






Wij, en derde partijen, maken op onze website gebruik van cookies. Wij gebruiken cookies om ervoor te zorgen dat onze website goed functioneert, om jouw voorkeuren op te slaan, om inzicht te verkrijgen in bezoekersgedrag, maar ook voor marketing en social media doeleinden (laten zien van gepersonaliseerde advertenties). Door op ‘Accepteren’ te klikken, ga je akkoord met het gebruik van alle cookies. In onze Cookieverklaring kun je meer lezen over de cookies die wij gebruiken en kun je jouw voorkeuren opslaan of wijzigen. Door ‘Weigeren’ te klikken ga je alleen akkoord met het gebruik van functionele cookies.